Article Versions Notes

Scandura G, Giallongo C, Puglisi F, Romano A, Parrinello NL, Zuppelli T, Longhitano L, Giallongo S, Di Rosa M, Musumeci G, et al. TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment. Antioxidants. 2022; 11(4):767. https://doi.org/10.3390/antiox11040767

Scandura, Grazia, Cesarina Giallongo, Fabrizio Puglisi, Alessandra Romano, Nunziatina Laura Parrinello, Tatiana Zuppelli, Lucia Longhitano, Sebastiano Giallongo, Michelino Di Rosa, Giuseppe Musumeci, and et al. 2022. "TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment" Antioxidants 11, no. 4: 767. https://doi.org/10.3390/antiox11040767

Scandura, G., Giallongo, C., Puglisi, F., Romano, A., Parrinello, N. L., Zuppelli, T., Longhitano, L., Giallongo, S., Di Rosa, M., Musumeci, G., Motterlini, R., Foresti, R., Palumbo, G. A., Li Volti, G., Di Raimondo, F., & Tibullo, D. (2022). TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment. Antioxidants, 11(4), 767. https://doi.org/10.3390/antiox11040767